Eyecare company Bausch + Lomb (NYSE:BLCO) reported in Q4 CY2024, with sales up 9.1% year on year to $1.28 billion. On the ...

Eye Care Experts at Bausch and Lomb: For over 150 years, we have focused on innovation and quality in eye care products, from contact lenses and solutions to eye drops, ointments, eye vitamins ...

After completing $300 billion in healthcare deals over several decades, there is one deal Bausch and Lomb ( BLCO) chairman ...

Reports Q4 revenue $1.28B, consensus $1.25B. “Underpinning our recent success is a commitment to long-term, profitable growth,” said Brent ...

Bausch + Lomb saw a broad-based growth across its three core segments. Vision care, its largest, saw revenue rise 9% to $723 million, while surgical increased 13% to $231 million. Pharmaceuticals rose ...

Helps creat a fluid stream to direct the solution into the affected areas. To guarantee sterility, each bottle is single use only Eye wash soltion helps to clear eyes of foregin material such as ...

Shares in ophthalmology specialist Bausch + Lomb (B+L) have lost almost 10% of ... intraocular lenses, and eye surgery products, and made revenues of $4.15 billion last year.

It's been estimated that those working remotely or in hybrid roles are clocking up to 11 hours daily on screens, significantly increasing the risk of developing digital eye strain (DES).

“I had seen Pina Bausch on VHS when I was an early teenager but live the first time? I was smashed,” he enthuses. “I was just like ‘wow’: stuntmen jumping in Nelken (Carnations), amazing ...

Jessica was a writer on the Wellness team, with a focus on health technology, eye care, nutrition and finding new approaches to chronic health problems. Expertise Public health, new wellness ...